23 related articles for article (PubMed ID: 16278285)
1. Distinct Metalloproteinase Expression and Functions in Systemic Sclerosis and Fibrosis: What We Know and the Potential for Intervention.
Leong E; Bezuhly M; Marshall JS
Front Physiol; 2021; 12():727451. PubMed ID: 34512395
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature.
Bonhomme O; André B; Gester F; de Seny D; Moermans C; Struman I; Louis R; Malaise M; Guiot J
Rheumatology (Oxford); 2019 Sep; 58(9):1534-1546. PubMed ID: 31292645
[TBL] [Abstract][Full Text] [Related]
3. Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis.
Saigusa R; Asano Y; Taniguchi T; Yamashita T; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sugawara K; Tsuruta D; Taniguchi T; Sato S
Proc Natl Acad Sci U S A; 2015 Dec; 112(49):15136-41. PubMed ID: 26598674
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases: a review of their structure and role in systemic sclerosis.
Peng WJ; Yan JW; Wan YN; Wang BX; Tao JH; Yang GJ; Pan HF; Wang J
J Clin Immunol; 2012 Dec; 32(6):1409-14. PubMed ID: 22767184
[TBL] [Abstract][Full Text] [Related]
5. (Not) talking about sex: a systematic comparison of sexual impairment in women with systemic sclerosis and other chronic disease samples.
Knafo R; Thombs BD; Jewett L; Hudson M; Wigley F; Haythornthwaite JA
Rheumatology (Oxford); 2009 Oct; 48(10):1300-3. PubMed ID: 19692458
[TBL] [Abstract][Full Text] [Related]
6. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.
Young-Min SA; Beeton C; Laughton R; Plumpton T; Bartram S; Murphy G; Black C; Cawston TE
Ann Rheum Dis; 2001 Sep; 60(9):846-51. PubMed ID: 11502611
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
Yamane K; Ihn H; Kubo M; Yazawa N; Kikuchi K; Soma Y; Tamaki K
J Rheumatol; 2000 Apr; 27(4):930-4. PubMed ID: 10782818
[TBL] [Abstract][Full Text] [Related]
8. Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement.
Moinzadeh P; Krieg T; Hellmich M; Brinckmann J; Neumann E; Müller-Ladner U; Kreuter A; Dumitrescu D; Rosenkranz S; Hunzelmann N
Exp Dermatol; 2011 Sep; 20(9):770-3. PubMed ID: 21707759
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
Asano Y; Ihn H; Yamane K; Yazawa N; Kubo M; Fujimoto M; Tamaki K
Arthritis Rheum; 2001 Jun; 44(6):1363-9. PubMed ID: 11407696
[TBL] [Abstract][Full Text] [Related]
10. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
Vancheeswaran R; Magoulas T; Efrat G; Wheeler-Jones C; Olsen I; Penny R; Black CM
J Rheumatol; 1994 Oct; 21(10):1838-44. PubMed ID: 7837147
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosis.
Asano Y; Ihn H; Kubo M; Jinnin M; Mimura Y; Ashida R; Tamaki K
Rheumatology (Oxford); 2006 Mar; 45(3):303-7. PubMed ID: 16278285
[TBL] [Abstract][Full Text] [Related]
12. Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature.
Jaovisidha K; Csuka ME; Almagro UA; Soergel KH
Semin Arthritis Rheum; 2005 Feb; 34(4):689-702. PubMed ID: 15692963
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
